Location History:
- Gex, FR (2009)
- Cessy, FR (2010 - 2011)
Company Filing History:
Years Active: 2009-2011
Title: **Innovative Contributions of Emmanuel Lepoul in G-Protein Coupled Receptor Research**
Introduction
Emmanuel Lepoul, an innovative inventor based in Cessy, France, has made significant contributions to the field of biochemistry through his groundbreaking work on G-protein coupled receptors. His intellectual property portfolio boasts four patents, with a focus on chemerin receptors and their novel ligands, which hold promise for therapeutic advancements.
Latest Patents
Among Emmanuel's notable inventions are two latest patents:
1. **Nucleic Acids Encoding ChemerinR Ligands**: This invention pertains to a G-protein coupled receptor and its novel ligand. It emphasizes the development of screening assays aimed at identifying candidate compounds that modulate the receptor's activity. Moreover, this invention aids in the diagnosis and treatment of diseases linked to the dysregulation of G-protein coupled receptor signaling.
2. **Methods of Identifying Modulators of ChemerinR Polypeptides**: Similar to the previous patent, this invention also deals with a G-protein coupled receptor and its novel ligand. It provides methods for screening candidate compounds and diagnostic assays relevant to the regulation of G-protein coupled receptor activities and related disorders.
Career Highlights
Emmanuel currently contributes his expertise at Euroscreen S.A., where his innovative research progresses the understanding of G-protein coupled receptors. His work has implications for numerous medical conditions, demonstrating a commitment to both science and patient care through innovation.
Collaborations
Throughout his career, Emmanuel has collaborated with talented colleagues such as Valeria Wittamer and Isabelle Migeotte. Together, these researchers push the boundaries of knowledge in their domain, fostering an environment conducive to innovation and excellence.
Conclusion
Emmanuel Lepoul's inventive spirit and dedication to research significantly advance our comprehension of G-protein coupled receptors. His latest patents not only demonstrate his innovative capabilities but also provide avenues for future medical breakthroughs. As he continues his work at Euroscreen S.A., the impact of his inventions in the realm of biochemistry and medicine will undoubtedly grow, paving the way for improved treatments and understanding of related diseases.